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Abstract To elucidate the effect of blood flow on gene transcrip- 
tion of C-type natriuretic peptide (CNP), human umbilical vein 
endothelial cells were exposed to shear stress in a cone-plate 
viscometer. Expression of CNP mRNA, evaluated by reverse 
transcriptiou-polymerase chain reaction, was markedly increased 
by exposure to shear stress of 24 dyne/cm 2 at 3 h. The CNP 
mRNA level was maintained until 12 h. Thus, the present study 
demonstrated for the first time that shear stress induces expres- 
sion of CNP gene in human endothelial cells. 
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the development of intimal lesions induced by air-drying injury 
in rat carotid arteries [8,9]. The endothelial production of CNP 
is reported to be augmented by cytokines such as TGF-f l  [3]. 
Recently, several studies indicated that mRNA expression of 
several peptides, that are synthesized in endothelial cell, are 
regulated by shear stress [10-12]. In the present study, to exam- 
ine the effect of shear stress on CNP gene expression, we have 
evaluated the presence of mRNA of CNP by reverse transcrip- 
tion-polymerase chain reaction (RT-PCR), in human endothe- 
lial cells exposed to a various degree of shear stress. 
2. Materials and methods 
1. Introduction 
C-type natriuretic peptide (CNP), a new member of the 
natriuretic peptide family, was identified in the porcine brain 
[1]. In contrast to other natriuretic peptides; ANP and BNP, 
CNP has not been detected in the heart and blood, and was 
believed to be a neuropeptide [2]. Recently, CNP has been 
identified in endothelial cells and recognized to be a vascular 
local mediator [3,4]. Natriuretic peptide family has at least three 
receptors, namely ANP-A receptor, ANP-B receptor and clear- 
ance receptor. ANP-A receptor and ANP-B receptor possess 
an intracellular guanylate cyclase domain [5]. Accordingly, 
natriuretic peptides increase intracellular cGMP via ANP-A 
receptor and ANP-B receptor. ANP and BNP activate selec- 
tively ANP-A receptor, whereas CNP potently and selectively 
activates the ANP-B receptor [1,6], ANP-A receptor and ANP- 
B receptor are both expressed in intact aortic media. However, 
in cultured smooth muscle cells that are known to be 'synthetic 
phenotype', ANP-A receptor becomes undetectable and ANP- 
B receptor becomes to be expressed ominantly [7]. Synthetic 
smooth muscle cells are major pathological contents of athero- 
sclerosis and neointimal lesion. Thus, CNP potentially plays an 
important role in vascular emodeling. Actually, Furuya et al. 
reported that CNP inhibits proliferation of cultured rat vascu- 
lar smooth muscle cells and that administration of CNP inhibits 
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2.1. Human umbilical vein endothelial cell culture 
Human umbilical vein endothelial cells (HUVEC) were isolated from 
the umbilical vein as described previously [13]. The cells were main- 
tained in MCDB131 (Chlorella Inc., Tokyo, Japan) supplemented with 
10% fetal bovine serum (FBS), 100 U/ml penicillin, 100/lg/ml strepto- 
mycin and 10/tg/ml human recombinant basic FGF (Dainippon Phar- 
maceutical Co., LTD., Osaka, Japan). Cells were subcultured, and the 
identification was performed by immunocytochemistry using anti-fac- 
tor VIII antibody. The purity of these cells was > 97%. 
2.2. Shear stress loading apparatus 
We used a shear stress loading apparatus (Toray Industries, Inc., 
Tokyo, Japan) that allowed us to expose cultured HUVEC to a well- 
defined laminar fluid flow. Our system is modified from the cone-plate 
viscometer device first described and characterized by Bussolari and 
Dewey [14]. The shear stress device consists of a cone that rotates above 
a stationary base plate containing the cultured HUVEC. The base plate 
is made by the 35-ram-diameter collagen coated polystyrene dish (Iwaki 
Glass Company, LTD., Tokyo, Japan). The cone makes an angle of 
0.5 ° with the culture plate and is coupled to a variable motor. The 
distance between the cone and the culture dish was adjusted to be 50 
ktm. This shear stress device was operated in CO2 incubator. 
2.3. Experimental protocol 
Confluent HUVEC on 35-mm-diameter collagen coated polystyrene 
dish was washed with PBS for three times and added 1 ml of culture 
media containing 10% FBS. The plate was placed in COz incubator for 
30 rain before xposure to shear stress. The culture dish was then placed 
in the cone-plate viscometer, and the cells were subjected to shear stress 
from 3 to 24 dyne/cm 2 for 1, 3, 6 or 12 h. The culture dish was then 
detached from the device, and the medium was discarded. For RNA 
isolation, 1 ml of Isogen (Nippon Gene Co., Ltd. Toyama, Japan) was 
added to the cells immediately, and the lysate was prepared. Stationary 
samples were obtained with the same procedure xcept shear stress 
exposure. 
2.4. RNA isolation 
Total RNA was isolated according to the manufacture's protocol of 
Isogen [15]. After isolation, total RNA samples were checked by gel 
electrophoresis in a 0.8% agarose gel (Molecular Grade Agarose, Bio- 
Rad, Richmond USA) stained by ethidium bromide. The concentra- 
tions of total RNA were then calculated by spectrophotometric meas- 
urements at 260 nm wavelength. 
2.5. Reverse transcription-polymerase chain reaction 
Semiquantative assessment of CNP transcript was performed as fol- 
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lows. First strand cDNA was synthesized in 20/.tl of 0.5 mM of dATP, 
dGTP, dTTP and dCTP, 2.5 ng/pl random hexamers, 50 mM KC1, 
20mM Tris-HCl, pH 8.4, 2.5 mM MgCI2, and 10 unit of SuperScript 
II RT (SUPERSCRIPT Preamplification System, Gibco, Gaithers- 
burg, USA) at 42°C for 50 rain using as template 1 pg aliquots of total 
RNA. One pg of cDNA synthesis product was amplified in a thermal 
cycler with Taq polymerase 2.5 U (Gibco) with 1 pM of forward/reverse 
primer for CNP (5'-ATGCATCTCTCCCAGCTGCT/3'- TACTCGC- 
CGGACCCTACAAT) and for GAPDH. Primers for GAPDH is syn- 
thesized as previously described [16]. The expected amplified products 
were 380 and 379 bp, respectively. After a 3 min 94°C denudation step, 
samples were subjected to 40 cycles of denudation (94°C for 1 rain), 
annealing (CNP, 55°C; GAPDH, 48°C for 1 rain) and extension (72°C 
for 1 min). Then 2.5 ~1 of PCR products was electrophoresed in 2% 
agarose gels containing ethidium bromide and examined under UV 
light. And then PCR products of CNP were transfered from agarose 
gels to Nylon membranes (Hybond-N+, Amersham, Buckinghamshire, 
UK) and hybridized ?'32p-labelled mid-region oligonucleotide (5'-GC- 
CGAAGGTCCCGC) corresponding to CNP nucleotide 392-398 and 
843-849, in 7% polyethylene glycol and 10% SDS at 37°C overnight. 
The blots were washed in 2 x SSC at room temperature for 10 min 
3 times. The blots were exposed to X-ray film (X- OMAT AR, Kodak, 
Rochester, USA) for 3 h at -80°C. 
3. Results 
3.1. Induction of CNP mRNA expression in HUVEC by shear 
s t ress  
Expression of CNP mRNA was not detected in the station- 
ary HUVEC. However, an exposure of HUVEC to a steady 
laminar fluid shear stress (magnitude, 20 dyne/cm 2)caused a 
marked increase in expression of CNP mRNA. Expected 380 
bp products were detected from 3 h to 12 h after onset of flow 
(Fig. 1). The degree of CNP mRNA expression per GAPDH 
measured by densitometry increased in a time dependent man- 
ner (57.8%13 h, 84.8%/6 h, 100%/12 h). 
The expression of CNP mRNA was not detected in HUVEC 
which were subjected to a low grade of shear stress (0 to 3 
dyne/cm 2)for the period of 12 h. However, ahigher shear stress 
exposure (12 and 24 dyne/cm 2)to HUVEC markedly increased 
the expression of CNP mRNA (Fig. 2). GAPDH expression 
was not altered by any of the shear stress examined in this 
study, as shown in the figures. 
4. Discussion 
Shear stress is a tractive force that acts in the direction of 
blood flow on the surface of the blood vessel and endothelial 
cells are always exposed to shear stress. Endothelial cells were 
once thought o be a passive, non-thrombogenic barrier. How- 
ever, endothelial cells are known to have mechanoreceptors by 
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Fig. 1. CNP and GAPDH gene xpression i HUVEC exposure to 
shear stress (24 dyne/cm 2) for 1, 3, 6, 12 h. PCR products of CNP were 
hybridized to 73zp-labelled mid-region oligonucleotide. 
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Fig. 2. Southern RT-PCR analysis of CNP mRNA in HUVEC sub- 
jected to shear stresses of 3 to 24 dyne/cm 2 for 12 h. 
which changes in blood flow or shear stress are recognized by 
the endothelial cell and the signal is transmitted to intracellular 
organelles [17]. Recently, several studies clarified that shear 
stress exerts an influence on the expression of mRNA such as 
tissue plasminogen activator, ICAM-1, TGF-fll and constitu- 
tive nitric oxide synthase (cNOS) mRNA [10-12,18]. Promoter 
analysis of these substance revealed a specific base arrange- 
ment; 'GAGACC' or 'GGTCTC', shear stress responsive le- 
ment (SSRE), exists in the promoter region of these gene [19]. 
Several in vivo investigations have revealed that high shear 
stress decreases wall thickening in diseased arteries and vascu- 
lar grafts [20,21]. The elevated expressions ofTGF-fl and cNOS 
may have been contributed to the suppression of neointima in 
response to hemodynamic force. 
CNP has a less potent ofvasodilatation, but has a magnitude 
more potent of growth suppression of vascular smooth muscle 
cells than ANP [1]. We hypothesized that the expression of 
CNP mRNA is regulated by shear stress and evaluated the 
expression of CNP mRNA by RT-PCR. It has been reported 
that CNP mRNA was detectable in cultured bovine aortic 
endothelial cell [3]. However, CNP or CNP mRNA has not 
been identified in human endothelial cells. In our experiments, 
CNP mRNA was not detected in the stationary HUVEC. How- 
ever, exposure of 24 dyne/cm 2 shear stress to HUVEC clearly 
increased CNP mRNA within 3 h. Shear stress of 12 dyne/cm 2 
for 12 h also induced the marked expression of CNP mRNA 
in HUVEC. Thus, the present study demonstrated for the first 
time that shear stress induces expression of CNP gene in human 
endothelial cells, As physiological arterial shear stress is re- 
ported to be approximately 20dyne/cm 2 [17], the present find- 
ings implicate that shear stress might be a major regulatory 
factor of in vivo CNP production i  endothelial cells. Consider- 
ing the previous reports on TGF-fl [3], there was a possibility 
that the expression of CNP in the present study may be augu- 
mented by TGF-fl, possibly up-regulated by shear stress. How- 
ever, the expression of CNP mRNA was not detected by stim- 
ulating the same HUVEC by TGF-fl (100 pM,l nM; 6 h) (data 
not shown), indicating that shear stress directly induced the 
expression of CNP mRNA. Regarding SSRE considered to be 
essential for shear-induced transcription, Ogawa et al. has re- 
cently identified the element in the second coding region and 
the 3'-untranslated region of CNP gene in mice [22]. The ele- 
ment has been also identified in the 3'-untranslated region of 
human CNP gene (personal communication with Dr. Shouji 
Tanaka of Suntory Research Institute, Kyoto, Japan). Changes 
in shear stress have been implicated in various clinical settings 
including atherosclerosis. Therefore, CNP which suppresses 
smooth muscle cell proliferation, especially of synthetic pheno- 
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types, might be one of the mechanisms of shear stress-regulat- 
ing vascular emodeling. 
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